Stock Analiz

Senseonics Holdings, Inc. SENS

Medical/Dental Instruments · data as of November 13, 2026

$10.58Market cap $580M
Open the interactive analysis →

Senseonics Holdings, Inc. (SENS) is a healthcare company listed in the US with a market value of about $580M. In the twelve months to September 30, 2026 it had revenue of $60M and net income of -$123M, a net margin of -204.2%.

Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 48% a year, a 5-year average ROIC of -135%.

About Senseonics

Senseonics is listed in the US and classified in medical/dental instruments. Revenue went from $38000 in 2015 to $35M in 2025, growth of about 98.0% a year. It was profitable in 1 of the last 10 years in our data. Its share count rose by 35% over three years (dilution for shareholders). It spends 90% of revenue on research and development.

Score: 1.2 / 5

Value0/5
Future growth3/5
Track record1/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • Revenue growth above 10% last year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • 5-year revenue growth above 8% a year
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S9.7
P/B7.5
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-19.7%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)56.9%
Revenue growth (5 yrs, per year)48.1%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-756.9%
ROIC (5-yr avg.)-135.0%
Profitable years (of last 10)1
Years paying a dividend—

Financials, last 10 years

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$60M$35M$22M$22M—$14M$5M$21M$19M$6M$332000
Net income-$123M-$69M-$79M-$60M$142M-$302M-$175M-$116M-$94M-$59M-$44M
Free cash flow-$114M-$60M-$63M-$71M-$67M-$56M-$68M-$137M-$92M-$56M-$38M
EPS (diluted)$-2.31$-1.66$-2.50$-2.20$-2.20$-14.40$-15.40$-12.20$-12.00$-10.20$-9.80
Net margin-204.2%-196.0%-349.8%-269.7%—-2211.9%-3539.5%-542.5%-496.9%-927.4%-13231.9%
ROIC—-66.7%-307.2%-71.5%-94.8%——-273.4%-49.0%-140.4%-236.2%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 6 analysts is $15.08, 43% above the current price; targets range from $10.00 to $20.00; the consensus rating is “Buy”; expected EPS is $-2.21 for the fiscal year ending December 31, 2026.

Frequently asked questions

Does Senseonics pay a dividend?

Not currently.

Is Senseonics a good stock to buy?

We do not give buy or sell advice. Senseonics scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.